-
1
-
-
0029161079
-
The risk of myocardial infarction associated with antihypertensive drug therapies
-
Psaty BM, Heckbert SR, Koepsell TD, Siscovick DS, Raghunathan TE, Weiss NS, Rosendaal FR, Lemaitre RN, Smith NL, Wahl PW, Wagner EH, Furbert CD, The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA 1995;274:620-625.
-
(1995)
JAMA
, vol.274
, pp. 620-625
-
-
Psaty, B.M.1
Heckbert, S.R.2
Koepsell, T.D.3
Siscovick, D.S.4
Raghunathan, T.E.5
Weiss, N.S.6
Rosendaal, F.R.7
Lemaitre, R.N.8
Smith, N.L.9
Wahl, P.W.10
Wagner, E.H.11
Furbert, C.D.12
-
2
-
-
0029132121
-
Nifedipine. Dose-related increase in mortality in patients with coronary heart disease
-
Furberg CD, Psaty BM, Meyer JV. Nifedipine. Dose-related increase in mortality in patients with coronary heart disease. Circulation 1995;92:1326-1331.
-
(1995)
Circulation
, vol.92
, pp. 1326-1331
-
-
Furberg, C.D.1
Psaty, B.M.2
Meyer, J.V.3
-
3
-
-
0029033524
-
The calcium channel blocker scare. Lessons for the future
-
Lenfant C. The calcium channel blocker scare. Lessons for the future. Circulation 1995;91:2855-2856.
-
(1995)
Circulation
, vol.91
, pp. 2855-2856
-
-
Lenfant, C.1
-
4
-
-
0022347420
-
Exclusion bias and the false relationship of reserpine and breast cancer
-
Horwitz RI, Feinstein AR. Exclusion bias and the false relationship of reserpine and breast cancer. Arch Intern Med 1985;145:1873-1875.
-
(1985)
Arch Intern Med
, vol.145
, pp. 1873-1875
-
-
Horwitz, R.I.1
Feinstein, A.R.2
-
5
-
-
0016177489
-
Reserpine and breast cancer
-
Boston Collaborative Drug Surveillance Program. Reserpine and breast cancer. Lancet 1974;2:669-671.
-
(1974)
Lancet
, vol.2
, pp. 669-671
-
-
-
6
-
-
0016284365
-
Retrospective study of the association between use of Rauwolfia derivatives and breast cancer in English women
-
Armstrong B, Stevens N. Retrospective study of the association between use of Rauwolfia derivatives and breast cancer in English women. Lancet 1974;672-675.
-
(1974)
Lancet
, pp. 672-675
-
-
Armstrong, B.1
Stevens, N.2
-
7
-
-
0016177489
-
Reserpine use in relation to breast cancer
-
Heinonen OP, Shapiro S. Reserpine use in relation to breast cancer. Lancet 1974; 675-677.
-
(1974)
Lancet
, pp. 675-677
-
-
Heinonen, O.P.1
Shapiro, S.2
-
8
-
-
0024460849
-
Calcium channel blockers in acute myocardial infarction and unstable angina: An overview
-
Held PH, Yusuf S. Calcium channel blockers in acute myocardial infarction and unstable angina: an overview. Br Med J 1989;299:1187-1192.
-
(1989)
Br Med J
, vol.299
, pp. 1187-1192
-
-
Held, P.H.1
Yusuf, S.2
-
9
-
-
0028245862
-
Calcium antagonists in the treatment of ischemic heart disease: Myocardial infarction
-
Held PH, Yusuf S. Calcium antagonists in the treatment of ischemic heart disease: myocardial infarction. Coron Artery Dis 1994;5:21-26.
-
(1994)
Coron Artery Dis
, vol.5
, pp. 21-26
-
-
Held, P.H.1
Yusuf, S.2
-
10
-
-
0029646426
-
Are calcium antagonists safe?
-
Messerli FH. Are calcium antagonists safe? [letter] Lancet 1995;346:767-768.
-
(1995)
Lancet
, vol.346
, pp. 767-768
-
-
Messerli, F.H.1
-
11
-
-
0029638819
-
Risks and benefits of calcium antagonists
-
Lichtlen PR. Risks and benefits of calcium antagonists [letter]. Lancet 1995; 346:962.
-
(1995)
Lancet
, vol.346
, pp. 962
-
-
Lichtlen, P.R.1
-
12
-
-
0029103247
-
Nifedipine in ischemic heart disease
-
Kloner RA. Nifedipine in ischemic heart disease. Circulation 1995;92:1074-1078.
-
(1995)
Circulation
, vol.92
, pp. 1074-1078
-
-
Kloner, R.A.1
-
13
-
-
0027399060
-
The fifth report of the joint national committee on detection, evaluation and treatment of high blood pressure (JNC V)
-
Joint National Committee. The fifth report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993;153:154-183.
-
(1993)
Arch Intern Med
, vol.153
, pp. 154-183
-
-
|